Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Rush Univ. Cook County Hosp. Chicago NICHD CRS
mi
from
Chicago, IL
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Rush Univ. Cook County Hosp. Chicago NICHD CRS
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Ann & Robert H. Lurie Children's Hospital of Chicago (LCH) CRS
mi
from
Chicago, IL
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Ann & Robert H. Lurie Children's Hospital of Chicago (LCH) CRS
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Tulane Univ. New Orleans NICHD CRS
mi
from
New Orleans, LA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Tulane Univ. New Orleans NICHD CRS
mi
from
New Orleans, LA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Univ. of Maryland Baltimore NICHD CRS
mi
from
Baltimore, MD
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Univ. of Maryland Baltimore NICHD CRS
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Children's Hosp. of Boston NICHD CRS
mi
from
Boston, MA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Children's Hosp. of Boston NICHD CRS
mi
from
Boston, MA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Boston Medical Center Ped. HIV Program NICHD CRS
mi
from
Boston, MA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Boston Medical Center Ped. HIV Program NICHD CRS
mi
from
Boston, MA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
WNE Maternal Pediatric Adolescent AIDS CRS
mi
from
Worcester, MA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
WNE Maternal Pediatric Adolescent AIDS CRS
mi
from
Worcester, MA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Children's Hospital of Michigan NICHD CRS
mi
from
Detroit, MI
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Children's Hospital of Michigan NICHD CRS
mi
from
Detroit, MI
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Rutgers - New Jersey Medical School CRS
mi
from
Newark, NJ
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Rutgers - New Jersey Medical School CRS
mi
from
Newark, NJ
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Bronx-Lebanon CRS
mi
from
Bronx, NY
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Bronx-Lebanon CRS
mi
from
Bronx, NY
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Jacobi Med. Ctr. Bronx NICHD CRS
mi
from
Bronx, NY
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Jacobi Med. Ctr. Bronx NICHD CRS
mi
from
Bronx, NY
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Nyu Ny Nichd Crs
mi
from
New York, NY
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Nyu Ny Nichd Crs
mi
from
New York, NY
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Metropolitan Hosp. NICHD CRS
mi
from
New York, NY
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Metropolitan Hosp. NICHD CRS
mi
from
New York, NY
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Columbia IMPAACT CRS
mi
from
New York, NY
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Columbia IMPAACT CRS
mi
from
New York, NY
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Strong Memorial Hospital Rochester NY NICHD CRS
mi
from
Rochester, NY
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Strong Memorial Hospital Rochester NY NICHD CRS
mi
from
Rochester, NY
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
SUNY Stony Brook NICHD CRS
mi
from
Stony Brook, NY
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
SUNY Stony Brook NICHD CRS
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
DUMC Ped. CRS
mi
from
Durham, NC
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
DUMC Ped. CRS
mi
from
Durham, NC
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
The Children's Hosp. of Philadelphia IMPAACT CRS
mi
from
Philadelphia, PA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
The Children's Hosp. of Philadelphia IMPAACT CRS
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
St. Jude Children's Research Hospital CRS
mi
from
Memphis, TN
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
St. Jude Children's Research Hospital CRS
mi
from
Memphis, TN
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Texas Children's Hosp. CRS
mi
from
Houston, TX
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Texas Children's Hosp. CRS
mi
from
Houston, TX
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Seattle Children's Research Institute CRS
mi
from
Seattle, WA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Seattle Children's Research Institute CRS
mi
from
Seattle, WA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
University of Puerto Rico Pediatric HIV/AIDS Research Program CRS
mi
from
San Juan,
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
University of Puerto Rico Pediatric HIV/AIDS Research Program CRS
mi
from
San Juan,
Click here to add this to my saved trials
Evaluation of the Pharmacokinetic Interaction Between PA-824 and Midazolam
A Phase 1, Open-label, Multi-Dose Study to Assess Pharmacokinetic Interaction Between PA-824 and Midazolam
Status: Enrolling
Updated:  1/12/2016
MDS Pharma Services
mi
from
Lincoln, NE
Evaluation of the Pharmacokinetic Interaction Between PA-824 and Midazolam
A Phase 1, Open-label, Multi-Dose Study to Assess Pharmacokinetic Interaction Between PA-824 and Midazolam
Status: Enrolling
Updated: 1/12/2016
MDS Pharma Services
mi
from
Lincoln, NE
Click here to add this to my saved trials
Food Effect Study on the Bioavailability and PK of PA-824 Tablets in Healthy Adult Subjects
A Phase 1, Randomized, Balanced, Single-Dose, Two-Treatment, Two-Period, Two-Sequence, Crossover, Open-Label Study of the Effect of Food on the Bioavailability and Pharmacokinetics of PA-824 Tablets in Healthy Adult Subjects
Status: Enrolling
Updated:  1/12/2016
MDS Pharma Services
mi
from
Lincoln, NE
Food Effect Study on the Bioavailability and PK of PA-824 Tablets in Healthy Adult Subjects
A Phase 1, Randomized, Balanced, Single-Dose, Two-Treatment, Two-Period, Two-Sequence, Crossover, Open-Label Study of the Effect of Food on the Bioavailability and Pharmacokinetics of PA-824 Tablets in Healthy Adult Subjects
Status: Enrolling
Updated: 1/12/2016
MDS Pharma Services
mi
from
Lincoln, NE
Click here to add this to my saved trials
Food Effect Study on the Bioavailability and PK of PA-824 Tablets in Healthy Adult Subjects (CL-009)
A Phase 1, Randomized, Balanced, Single-Dose, Two-Period, Two-Sequence, Crossover, Open-Label Study of the Effect of Food on the Bioavailability and Pharmacokinetics of PA-824 Tablets in Healthy Adult Subjects
Status: Enrolling
Updated:  1/12/2016
MDS Pharma Services (Celerion)
mi
from
Lincoln, NE
Food Effect Study on the Bioavailability and PK of PA-824 Tablets in Healthy Adult Subjects (CL-009)
A Phase 1, Randomized, Balanced, Single-Dose, Two-Period, Two-Sequence, Crossover, Open-Label Study of the Effect of Food on the Bioavailability and Pharmacokinetics of PA-824 Tablets in Healthy Adult Subjects
Status: Enrolling
Updated: 1/12/2016
MDS Pharma Services (Celerion)
mi
from
Lincoln, NE
Click here to add this to my saved trials
PK Interaction Between Rifapentine or Rifampicin and a Single Dose of TMC207 in Healthy Subjects (TMC207-CL002)
A Phase I Open-label Trial to Investigate the Pharmacokinetic Interaction Between Rifapentine or Rifampicin and a Single Dose of TMC207 in Healthy Subjects
Status: Enrolling
Updated:  1/12/2016
Celerion (MDS Pharma Services)
mi
from
Lincoln, NE
PK Interaction Between Rifapentine or Rifampicin and a Single Dose of TMC207 in Healthy Subjects (TMC207-CL002)
A Phase I Open-label Trial to Investigate the Pharmacokinetic Interaction Between Rifapentine or Rifampicin and a Single Dose of TMC207 in Healthy Subjects
Status: Enrolling
Updated: 1/12/2016
Celerion (MDS Pharma Services)
mi
from
Lincoln, NE
Click here to add this to my saved trials
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Orange, CA
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Orange, CA
Click here to add this to my saved trials
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
San Diego, CA
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Washington,
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Atlanta, GA
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Chicago, IL
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Peoria, IL
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Peoria, IL
Click here to add this to my saved trials
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Indianapolis, IN
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Iowa City, IA
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Iowa City, IA
Click here to add this to my saved trials
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Louisville, KY
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
New Orleans, LA
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
New Orleans, LA
Click here to add this to my saved trials
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Detroit, MI
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Kansas City, MO
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Omaha, NE
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Las Vegas, NV
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
New Brunswick, NJ
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
New York, NY
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
New York, NY
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Cincinnati, OH
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Columbus, OH
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Pittsburgh, PA
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Nashville, TN
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Fort Worth, TX
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Houston, TX
Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials